News on research and diagnostic development for pathogenic diseases.
At least two early-access users, at Massachusetts General Hospital and at Weill Cornell, have explored the new platform for infectious disease testing.
The Elite InGenius has the sample prep capabilities typical of high-throughput platforms, yet it can run more samples than smaller instruments.
The firm saw strong growth in respiratory illness assays and lead testing, which was offset by a decline in C. difficile testing.
The firm saw 60 percent revenue growth in molecular diagnostics, including 88 percent growth in its Solana system.
The partners said they have agreed to work together on projects in a range of diseases, as well as establish research alliances with groups in China and Africa.
